{
     "PMID": "23752093",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20140813",
     "LR": "20171116",
     "IS": "1873-7064 (Electronic) 0028-3908 (Linking)",
     "VI": "73",
     "DP": "2013 Oct",
     "TI": "mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling.",
     "PG": "192-203",
     "LID": "10.1016/j.neuropharm.2013.05.037 [doi] S0028-3908(13)00251-7 [pii]",
     "AB": "Administration of N-methyl-D-aspartate receptors (NMDAR) antagonists initiates a rapid anti-depressant response requiring mammalian Target of Rapamycin Complex 1 (mTORC1) kinase; however the molecular mechanism is unknown. We have determined that upon NMDAR blockade, dendritic gamma-amino-butyric acid B receptors (GABABR) facilitate dendritic calcium entry. The GABABR-mediated increase in calcium signal requires the availability of dendritic L-type calcium channels. Moreover, GABABR can activate mTOR and increase mTOR dependent expression of BDNF under the same NMDAR blocked conditions. In vivo, blocking GABABR prevents the fast-acting, anti-depressant effect of the NR2B antagonist, Ro-25-6891, decreases active mTORC1 kinase, and reduces expression of BDNF and the AMPA receptor subunit GluA1. These findings propose a novel role for GABABRs in the antidepressant action of NR2B antagonists and as an initiator/regulator of mTORC1-mediated translation.",
     "CI": [
          "Published by Elsevier Ltd."
     ],
     "FAU": [
          "Workman, E R",
          "Niere, Farr",
          "Raab-Graham, Kimberly F"
     ],
     "AU": [
          "Workman ER",
          "Niere F",
          "Raab-Graham KF"
     ],
     "AD": "Center for Learning and Memory, Section of Neurobiology, University of Texas at Austin, Austin, TX 78712, USA.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, U.S. Gov't, Non-P.H.S."
     ],
     "DEP": "20130608",
     "PL": "England",
     "TA": "Neuropharmacology",
     "JT": "Neuropharmacology",
     "JID": "0236217",
     "RN": [
          "0 (Brain-Derived Neurotrophic Factor)",
          "0 (Calcium Channels, L-Type)",
          "0 (Cytoskeletal Proteins)",
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (GABA Antagonists)",
          "0 (GABA-B Receptor Agonists)",
          "0 (Multiprotein Complexes)",
          "0 (Nerve Tissue Proteins)",
          "0 (Organophosphorus Compounds)",
          "0 (Piperidines)",
          "0 (Receptors, AMPA)",
          "0 (Receptors, GABA-B)",
          "0 (Ro-25-6891)",
          "0 (activity regulated cytoskeletal-associated protein)",
          "0 (glutamate receptor ionotropic, AMPA 1)",
          "76726-92-6 (2-Amino-5-phosphonovalerate)",
          "87TI61875H (CGP 35348)",
          "EC 2.7.1.1 (TOR Serine-Threonine Kinases)",
          "EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1)",
          "H789N3FKE8 (Baclofen)",
          "SY7Q814VUP (Calcium)"
     ],
     "SB": "IM",
     "MH": [
          "2-Amino-5-phosphonovalerate/pharmacology",
          "Animals",
          "Baclofen/pharmacology",
          "Brain-Derived Neurotrophic Factor/*metabolism",
          "Calcium/metabolism",
          "Calcium Channels, L-Type/drug effects/metabolism",
          "Cells, Cultured",
          "Cytoskeletal Proteins/*metabolism",
          "Excitatory Amino Acid Antagonists/pharmacology",
          "GABA Antagonists/pharmacology",
          "GABA-B Receptor Agonists/pharmacology",
          "Hippocampus/metabolism",
          "Humans",
          "Immobility Response, Tonic/drug effects",
          "Male",
          "Mechanistic Target of Rapamycin Complex 1",
          "Mice",
          "Multiprotein Complexes/*metabolism",
          "Nerve Tissue Proteins/*metabolism",
          "Organophosphorus Compounds/pharmacology",
          "Piperidines/pharmacology",
          "Prefrontal Cortex/drug effects/metabolism",
          "Primary Cell Culture",
          "Receptors, AMPA/metabolism",
          "Receptors, GABA-B/*metabolism",
          "Signal Transduction/drug effects",
          "TOR Serine-Threonine Kinases/*metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Calcium imaging",
          "GABA(B) receptors",
          "Hippocampal neurons",
          "L-type calcium channels",
          "NMDA receptors",
          "Prefrontal cortex",
          "Protein synthesis",
          "Rapid antidepressant",
          "mTORC1"
     ],
     "EDAT": "2013/06/12 06:00",
     "MHDA": "2014/08/15 06:00",
     "CRDT": [
          "2013/06/12 06:00"
     ],
     "PHST": [
          "2012/12/04 00:00 [received]",
          "2013/05/16 00:00 [revised]",
          "2013/05/27 00:00 [accepted]",
          "2013/06/12 06:00 [entrez]",
          "2013/06/12 06:00 [pubmed]",
          "2014/08/15 06:00 [medline]"
     ],
     "AID": [
          "S0028-3908(13)00251-7 [pii]",
          "10.1016/j.neuropharm.2013.05.037 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropharmacology. 2013 Oct;73:192-203. doi: 10.1016/j.neuropharm.2013.05.037. Epub 2013 Jun 8.",
     "term": "hippocampus"
}